about
H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccinesH5N1 viruses and vaccinesLive, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferretsEurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza viruspH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGNLack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret modelAnimal models for SARS and MERS coronavirusesH5N1 vaccines in humansInfluenza virus vaccines: lessons from the 2009 H1N1 pandemicInfluenza a virus assembly intermediates fuse in the cytoplasmVaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesReplication and immunogenicity of swine, equine, and avian h3 subtype influenza viruses in mice and ferretsEngineering H5N1 avian influenza viruses to study human adaptationThe soft palate is an important site of adaptation for transmissible influenza virusesReceptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferretsNonreplicating influenza A virus vaccines confer broad protection against lethal challengeStructure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesProphylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenzaCharacterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illnessA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsReplication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets.Avian influenza h6 viruses productively infect and cause illness in mice and ferrets.Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.Development of effective vaccines against pandemic influenza.Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virusScientific barriers to developing vaccines against avian influenza viruses.Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccinesToxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets.Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination.
P50
Q21090076-E3066DDD-011A-433A-AEA8-9EF6C401371CQ21131612-C3BA7DB7-0D4C-4F2A-8A4C-29479EB5B111Q21563426-EC386C9B-DA66-42F4-B044-CDB1DBEF2A79Q23921202-E7216770-0F17-4062-8FCD-0FB967EA8370Q24563490-AB30694B-F44F-4A6B-85BF-A998DF7341E4Q24670511-2EDA2765-5B98-443A-9F87-AC6647DE4B0AQ26799857-0392E703-DF7A-4D5A-B81A-031890282829Q27000896-23D72C4B-C852-42D3-AEB3-1AAE3970A9A7Q27027029-1541A8AF-3CA9-4A8D-A2A5-3DB30E64CD50Q27330190-700C5AFC-25BD-445F-ACCF-647CF573EB2CQ27644544-B551F73C-A031-442B-8271-B11E6CC4F1CDQ28384099-B7999EB9-9675-4EF8-9214-4C125B38F3AAQ28386710-873FA68A-0885-4FB4-A1F4-EAEB2F448E9EQ28390270-21A8BC18-3336-461A-B29B-75DF518DB923Q28390287-C3EBC44F-4BEF-405D-BE49-8B96B265579CQ28392109-544A717E-0053-4CB1-97C0-E50EEAF4ABD8Q28396120-084DC14E-80DA-40B0-8814-B137D643B399Q28757651-17B2DF3E-BE97-498C-B9BA-FBBD6E2AE933Q29615389-641BB64D-5A0A-4A74-BDE8-A7C1AC458A17Q30204020-103DE1D9-206B-411D-A314-D79C1F36D7ADQ30206089-B78CA37C-D819-4E87-8716-898CC49E6DD9Q30227151-A3A0044B-74CF-48D1-9454-EBF32471235EQ30228780-0C445026-BAC1-4164-A2B1-1EB432BCD914Q30332763-9A6C409B-DD14-4AAA-9E16-B3F779885A5DQ30335783-9ABE775F-4BD4-4D0F-A44C-29BD66B13BADQ30352566-67825BAF-AE69-4BAD-92D0-A79AB10FA11FQ30357270-BA63030B-941D-4551-BE1F-350273B1AB84Q30359896-89D8A2DC-4FBD-4693-8442-1E5F168BC49DQ30360439-C8B3F0F9-9493-4C88-A61B-29D5B327FEEFQ30360468-6CD9FC8F-CBF0-4484-BFF1-5F1AFBBE5DD3Q30361939-09EC824B-4D0D-42AC-B133-0F43195FEFE0Q30362332-0E4B91E9-7304-4828-AC13-DEE9BDE67DE6Q30362811-80FDF495-E5F4-4734-9070-06A92FC30D56Q30365696-714F10FD-818B-4972-A211-B6134FA9A246Q30366037-B2070D64-95B0-453D-9BCA-64F2866A6A32Q30366406-23CF90A5-D441-4D24-9ADA-5E47E8AB3963Q30369136-9DD4EA4C-6FB7-410E-9E7B-A5DED5D5643BQ30370303-DEBDEF9C-9B64-4A3A-B37A-825D3DC73D64Q30374887-EA5F2164-AC8B-4E64-A01D-31CD8DB953B6Q30375754-ED7B510D-0954-49D3-94E0-64A4229CAE90
P50
description
virologist and physician
@en
viroloog
@nl
name
Kanta Subbarao
@ast
Kanta Subbarao
@en
Kanta Subbarao
@es
Kanta Subbarao
@nl
Kanta Subbarao
@sl
type
label
Kanta Subbarao
@ast
Kanta Subbarao
@en
Kanta Subbarao
@es
Kanta Subbarao
@nl
Kanta Subbarao
@sl
prefLabel
Kanta Subbarao
@ast
Kanta Subbarao
@en
Kanta Subbarao
@es
Kanta Subbarao
@nl
Kanta Subbarao
@sl
P108
P214
P244
P106
P1153
7102213212
P214
P244
n2007184625
P31
P496
0000-0003-1713-3056
P569
2000-01-01T00:00:00Z
P734
P735
P7859
lccn-n2007184625